Sort by
Refine Your Search
-
) Positions PhD Positions Country Israel Application Deadline 3 Jul 2025 - 10:46 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
) Positions PhD Positions Country Israel Application Deadline 20 Jun 2025 - 10:34 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
) Positions PhD Positions Country Israel Application Deadline 31 May 2025 - 15:00 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
) Positions PhD Positions Country Israel Application Deadline 21 Jun 2025 - 15:14 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
(R3) Positions PhD Positions Country Israel Application Deadline 31 May 2025 - 14:45 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework
-
Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD Position Available in the Lab of Prof. Einav Gross
-
Researcher (R3) Positions PhD Positions Country Israel Application Deadline 27 Jun 2025 - 10:39 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research
-
Profile Established Researcher (R3) Positions PhD Positions Country Israel Application Deadline 1 Aug 2025 - 10:29 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Is the job funded through
-
) Positions PhD Positions Country Israel Application Deadline 31 May 2025 - 00:00 (Asia/Jerusalem) Type of Contract Temporary Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Jun 2025 Is the job
-
🔬 Exciting Research Opportunity: PhD/MSc Position in Cancer Therapeutics🏢 Eastern R&D Center, Israel, Ariel University, Israel.Our lab is pioneering peptide-based theranostic agents